BioCentury
ARTICLE | Company News

NovImmune hematology news

October 22, 2012 7:00 AM UTC

The NovImmune-led FIGHT HLH consortium received €6 million ($7.8 million) from the EU's Seventh Framework Program (FP7) to develop the company's NI-0501 to treat hemophagocytic lymphohistiocytosis (H...